MicroCHIPS’ Device Delivers In First-in-Human Clinical Trial
This article was originally published in Start Up
Executive Summary
It’s been a long road for MicroCHIPS, founded in 1999 to develop an implantable device capable of delivering discrete drug doses repeatedly over long periods of time. The company recently published results of its first clinical trial, establishing proof-of-concept and perhaps more importantly, indicating that after many years, it now has a focused plan, if not a timeline, for commercialization.